We can no longer simply worry about the enrollment form as the only hurdle in therapy initiation. We must view the entire patient journey as an interconnected set of challenges that need solving. And I believe achieving that goal is within reach.
Hospitals’ pharmacy spending is projected to rise by 3.42% next year, according to a new report. Specialty drugs, including Ozempic and Humira, as well as neurology medications are the primary drivers of this increase in pharmacy expenses.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Lyfegen, a startup that provides software for value-based drug contracting, recently raised $8 million in an oversubscribed Series A financing round. With the new funds, the company — which is based in Switzerland and New York — plans to expand its presence in the U.S., where drug costs are the highest in the world.
In recent years, a number of niche vendors have entered the market, promising significant savings for payers if they “carve-out” specialty pharmacy services from integrated pharmacy benefits management (PBM). While the savings they claim to provide sound undeniably attractive, they are often greatly exaggerated.
Adam Schechter, an adviser to Merck's CEO, said at the Veeva Summit Tuesday that many primary care diseases - such as cardiovascular disease and Alzheimer's - still have significant unmet needs.
Specialty drugs are outpacing traditional drugs in a major way, a new PwC report says. This is a real concern in terms of controlling overall medical costs.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Need proof that orphan indication’s the way to go? The demand for specialty medications – and their premium pricing – is driving up the total American spend on medication, a new study says. A revenue darling for most budding biotechs, specialty drugs acccounted for $124.1 billion of medication dollars spent, out of a total of […]
Specialty drugs – the costly medications used to treat complex disease like cancer and Hepatitis C – have become a hot-button topic given the fact that healthcare spending is perpetually on the rise. After a five-year contraction in healthcare spending growth, medical costs are projected to climb another 6.8 percent in 2015, according to the Health […]